Author:
Hayashi Ayano,Mizuno Kayoko,Shinkawa Kanna,Sakoda Kazunori,Yoshida Satomi,Takeuchi Masato,Yanagita Motoko,Kawakami Koji
Abstract
Abstract
Background
Diabetic kidney disease (DKD) is the most common disease among patients requiring dialysis for the first time in Japan. Multidisciplinary care (MDC) may prevent the progression of kidney failure. However, the effectiveness and timing of MDC to preserve kidney function in patients with DKD is unclear. Therefore, the aim of this study was to investigate whether MDC for patients with DKD affects the preservation of kidney function as well as the timing of MDC in clinical practice.
Methods
In this retrospective cohort study, we identified patients with type 2 diabetes mellitus and DKD from April 2012 to January 2020 using a nationwide Japanese healthcare record database. The fee code for medical guidance to prevent dialysis in patients with diabetes was used to distinguish between the MDC and non-MDC groups. The primary outcome was a 40% decline in the estimated glomerular filtration rate, and secondary outcomes were death, hospitalization, permanent dialysis, kidney failure with replacement therapy, and emergency temporary catheterization. Propensity score matching was performed, and Kaplan–Meier and multivariable Cox regression analyses were performed.
Results
Overall, 9,804 eligible patients met the inclusion criteria, of whom 5,614 were matched for the main analysis: 1,039 in the MDC group, and 4,575 in the non-MDC group. The primary outcome did not differ between the groups (hazard ratio: 1.18, [95% confidence interval: 0.99–1.41], P = 0.07). The groups also did not differ in terms of the secondary outcomes. Most patients with DKD received their first MDC guidance within 1 month of diagnosis, but most received guidance only once per year.
Conclusions
Although we could not demonstrate the effectiveness of MDC on kidney function in patients with DKD, we clarified the characteristics of such patients assigned the fee code for medical guidance to prevent dialysis related to diabetes.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. https://doi.org/10.1016/S0140-6736(20)30045-3.
2. Hanafusa N, Abe M, Jyouki N, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2021). (in Japanese). J Jpn Soc Dial Ther. 2022;54(12):611–57.
3. Ministry of Health, Labour and Welfare. 2020 Overview of national healthcare cost (in Japanese). Updated 2022/11/30. Accessed 2023/4/1, https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/20/index.html.
4. Siddiqui K, George TP, Joy SS, Alfadda AA. Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes. Front Endocrinol (Lausanne). 2022;13:1079725. https://doi.org/10.3389/fendo.2022.1079725.
5. Hannan M, Ansari S, Meza N, et al. Risk factors for CKD progression: overview of findings from the CRIC study. Clin J Am Soc Nephrol. 2021;16(4):648–59. https://doi.org/10.2215/CJN.07830520.